Fludarabine, mitoxantrone and dexametasone in the treatment of relapsed and refractory low-grade non-Hodgkin lymphoma.

被引：0
|
作者：
Sawczuk-Chabin, J
Kalinka, E
Centkowski, P
Budziszewska, K
Ceglarek, B
Najda, J
Blasinska-Morawiec, M
Sulek, K
Holowiecki, J
Konopka, L
Warzocha, K
机构：
[1] Inst Hematol & Blood Transfus, Dept Hematol, Warsaw, Poland
[2] Reg Canc Ctr, Dept Proliferat Dis, Lodz, Poland
[3] Mil Inst Med, Dept Hematol, Warsaw, Poland
[4] Inst Hematol & Blood Transfus, Dept Hematol & Internal Med, Warsaw, Poland
[5] L Warynski Silesian Med Acad, Dept Hematol, Katowice, Poland
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.4738.4738
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4738
引用
收藏
页码：265B / 265B
页数：1
相关论文
共 50 条
  • [31] Conditioning with treosulfan and fludarabine for patients with refractory or relapsed non-Hodgkin lymphoma (NHL)
    Schmitt, M.
    Sayer, H. G.
    Hilgendorf, I
    Treschl, A.
    Junghanss, C.
    Borchert, K.
    Koenigsmann, M.
    Casper, J.
    Freund, M.
    Kahl, C.
    ONKOLOGIE, 2010, 33 : 164 - 164
  • [32] Conditioning with treosulfan and fludarabine for patients with refractory or relapsed non-Hodgkin's lymphoma
    Schmitt, M.
    Trenschel, R.
    Sayer, H. G.
    Hilgendorf, I.
    Treschl, A.
    Glass, A.
    Junghanss, C.
    Borchert, K.
    Koenigsmann, M.
    Casper, J.
    Beelen, D. W.
    Freund, M.
    Kahl, C.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S247 - S247
  • [33] Bendamustine, vincristine, prednisolone in relapsed and refractory low grade non-Hodgkin's lymphoma
    Kath, R
    Blumenstengel, K
    Fricke, HJ
    Peters, HD
    Höffken, K
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2001, 126 (08) : 198 - 202
  • [34] Conditioning with Treosulfan and Fludarabine for Patients with Refractory or Relapsed Non-Hodgkin Lymphoma (NHL)
    Schmitt, Michael
    Trenschel, Rudolf
    Sayer, Herbert G.
    Schneider, Catarina
    Glass, Aenne
    Hilgendorf, Inken
    Treschl, Anne
    Junghanss, Christian
    Borchert, Kersten
    Koenigsmann, Michael
    Casper, Jochen
    Beelen, Dietrich
    Freund, Mathias
    Kahl, Christoph
    BLOOD, 2011, 118 (21) : 1753 - 1753
  • [35] Bendamustine: A novel alkylating agent for relapsed low-grade non-Hodgkin's lymphoma
    Reddy, GK
    D'Orazio, A
    CLINICAL LYMPHOMA & MYELOMA, 2005, 6 (03): : 171 - 172
  • [36] Current treatment of follicular and low-grade non-Hodgkin's lymphoma
    Linch, D
    ANTI-CANCER DRUGS, 2001, 12 : S5 - S9
  • [37] Liposomal daunorubicin (Daunoxome®) is active in the treatment of relapsed/refractory low grade and intermediate grade non-Hodgkin's lymphoma
    Tulpule, A
    Rarick, MU
    Kolitz, J
    Myers, A
    Bernstein, J
    Harvey-Buchanan, L
    Espina, BM
    Ptaszynski, M
    Mukwaya, G
    Levine, AM
    BLOOD, 1998, 92 (10) : 241B - 241B
  • [38] Treatment of low-grade non-Hodgkin lymphomas with fludarabine and mitoxantrone followed by rituximab maintenance: Results of a phase II study.
    Psyrri, Amanda
    Dimopoulos, Meletios A.
    Fountzilas, George
    Tsatalas, Constantinos
    Anagnostopoulos, Athanasios
    Papageorgiou, Sotirios
    Xiros, Nikolaos
    Economopoulos, Theofanis
    BLOOD, 2006, 108 (11) : 261B - 262B
  • [39] Evaluation of docetaxel in the treatment of relapsed or refractory patients with intermediate and high grade non Hodgkin lymphoma.
    Romero, BS
    Chajón, E
    BLOOD, 1998, 92 (10) : 240B - 240B
  • [40] FND regimen (Fludarabine, mitoxantrone and dexamethasone) is an effective combination for follicular non-Hodgkin's lymphoma.
    Dell'Olio, M
    Cascavilla, N
    Musto, P
    Bodenizza, CA
    Melillo, L
    Nobile, M
    Minervini, MM
    Carella, AM
    BLOOD, 2002, 100 (11) : 300B - 300B
12345